The pathogenesis of venous thromboembolism: Evidence for multiple interrelated causes

被引:61
作者
Brouwer, Jan-Leendert P. [1 ]
Veeger, Nic J. G. M. [1 ]
Kluin-Nelemans, Hanneke C. [1 ]
van der Meer, Jan [1 ]
机构
[1] Univ Groningen, Med Ctr, Dept Hematol, Div Hameostasis Thrombosis & Rheol, NL-9713 GZ Groningen, Netherlands
关键词
D O I
10.7326/0003-4819-145-11-200612050-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Venous thromboembolism (VTE) is thought to result from interactions between multiple genetic and environmental risk factors. Objective: To assess the contribution of multiple thrombophilic defects and exogenous risk factors to the absolute risk for VTE. Design: Retrospective family cohort study. Setting: Single university hospital. Participants: 468 relatives of 91 probands with a symptomatic hereditary deficiency of protein S, protein C, or antithrombin. Measurements: All relatives were tested for 10 thrombophilic deficiencies and defects in addition to the index deficiency and were assessed for exogenous risk factors (surgery, trauma, immobilization, use of oral contraceptives, and pregnancy). The authors compared annual incidences and relative risks for VTE in deficient and nondeficient relatives. Results: Annual incidences of VTE in relatives with 0, 1, and 2 or more additional thrombophilic deficiencies or defects were 1.16 (95% Cl, 0.60 to 2.03), 1.75 (Cl, 1.17 to 2.53), and 2.64 (Cl, 1.67 to 3.96) per 100 person-years, respectively, compared with 0.06 (CI, 0.002 to 0.33) per 100 person-years in nondeficient relatives without additional deficiencies or defects. Adjusted relative risks were 16.3 (CI, 2.0 to 131.0), 50.3 (6.5 to 389.7), and 102.8 (12.5 to 843.4). Of deficient relatives, 38% with no additional defect, 57% with 1 additional defect, and 81 % with 2 or more additional defects had VTE at age 65 years compared with 5% of nondeficient relatives (P < 0.001). In deficient relatives with additional deficiencies or defects, exogenous risk factors increased the risk for VTE from 1.20% to 2.51% per year (relative risk, 2.1 [CI, 1.1 to 4.2]). Limitations: This was a retrospective study without the ability to distinguish interactions between specific thrombophilic deficiencies and defects. Conclusion: Additional thrombophilic defects and exogenous risk factors increase the risk for VTE in persons with hereditary deficiencies of protein S, protein C, or antithrombin and provide evidence that multiple genetic and environmental risk factors contribute to VTE.
引用
收藏
页码:807 / 815
页数:9
相关论文
共 27 条
[1]  
ALLAART CF, 1995, BRIT MED J, V311, P910
[2]   A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
PATWARDHAN, NA ;
JOVANOVIC, B ;
FORCIER, A ;
DALEN, JE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938
[3]   DETERMINATION OF FREE AND TOTAL HOMOCYSTEINE IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
ARAKI, A ;
SAKO, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 422 :43-52
[4]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[5]   Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification [J].
Brouwer, JLP ;
Veeger, NJGM ;
van der Schaaf, W ;
Kluin-Nelemans, HC ;
van der Meer, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (05) :703-710
[6]   Laboratory markers in the diagnosis of venous thromboembolism [J].
Caprini, JA ;
Glase, CJ ;
Anderson, CB ;
Hathaway, K .
CIRCULATION, 2004, 109 (12) :I4-I8
[7]   The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency [J].
Castaman, G ;
Tosetto, A ;
Cappellari, A ;
Ruggeri, M ;
Rodeghiero, F .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (04) :321-326
[8]  
Danneberg J, 1998, CLIN CHEM, V44, P349
[9]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[10]  
DESTEFANO V, 1994, THROMB HAEMOSTASIS, V72, P352